0001104659-14-014163.txt : 20140227 0001104659-14-014163.hdr.sgml : 20140227 20140227160132 ACCESSION NUMBER: 0001104659-14-014163 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140227 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140227 DATE AS OF CHANGE: 20140227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UFP TECHNOLOGIES INC CENTRAL INDEX KEY: 0000914156 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS FOAM PRODUCTS [3086] IRS NUMBER: 042314970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12648 FILM NUMBER: 14648900 BUSINESS ADDRESS: STREET 1: 172 EAST MAIN ST CITY: GEORGETOWN STATE: MA ZIP: 01833 BUSINESS PHONE: 5083522200 MAIL ADDRESS: STREET 1: 172 EAST MAIN ST CITY: GEORGETOWN STATE: MA ZIP: 02135 8-K 1 a14-6990_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

Current Report Pursuant to

Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 27, 2014

 

UFP Technologies, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-12648

 

04-2314970

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

172 East Main Street, Georgetown, MA

 

01833-2107

(Address of Principal Executive Offices)

 

(Zip Code)

 

(978) 352-2200

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02                                           Results of Operations and Financial Condition.

 

On February 27, 2014, UFP Technologies, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2013.  A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

 

Limitation on Incorporation by Reference.    The information furnished in this Item 2.02,  including the press release attached hereto as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Cautionary Note Regarding Forward-Looking Statements.     Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements.  Please refer to the cautionary note in the press release regarding these forward-looking statements.

 

Item 9.01                                           Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press release dated February 27, 2014 of UFP Technologies, Inc. announcing its financial results for the fourth quarter and year ended December 31, 2013.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: February 27, 2014

UFP TECHNOLOGIES, INC.

 

 

 

 

 

By:

/s/ Ronald J. Lataille

 

 

Ronald J. Lataille, Chief Financial
Officer and Vice President

 

3



 

EXHIBIT INDEX

 

Exhibit

Number

 

Description

 

 

 

99.1

 

Press release dated February 27, 2014 of UFP Technologies, Inc. announcing its financial results for the fourth quarter and year ended December 31, 2013.

 

4


EX-99.1 2 a14-6990_1ex99d1.htm EX-99.1

Exhibit 99.1

 

UFP Technologies, Inc.

 

www.ufpt.com

172 East Main Street

 

Contact: Ron Lataille

Georgetown MA 01833 USA

 

978-352-2200

 

FOR IMMEDIATE RELEASE

 

UFP Technologies Announces Record 2013 Results

 

Georgetown, Mass., February 27, 2014.  UFP Technologies, Inc. (Nasdaq: UFPT), a manufacturer of packaging and component products, today reported net income of $11.3 million or $1.59 per diluted common share outstanding for its fiscal year ended December 31, 2013, 3.5% higher than net income of $10.9 million or $1.55 per diluted common share outstanding for its 2012 fiscal year.  Sales for 2013 were $139.2 million, 6.3% higher than 2012 sales of $131.0 million.

 

For its fourth quarter ended December 31, 2013, the Company reported net income of $3.4 million or $0.47 per diluted common share outstanding, 5.4% more than net income of $3.2 million or $0.45 per diluted common share outstanding in the same period of 2012.  Sales for the fourth quarter 2013 were $35.0 million versus 2012 fourth quarter sales of $33.4 million.

 

“I am pleased with our 2013 results,” said R. Jeffrey Bailly, Chairman and CEO. “This was our eighth consecutive year of record earnings and fourth straight year of record sales.  We are still experiencing strong demand for our medical products. We have also seen a modest rebound in military demand, although sales remain below historical levels. In the automotive market, we continue to manage legacy program attrition but still expect modest net growth in 2014.”

 

“Overall, market conditions remain soft, so we will keep strengthening our platform to improve our competitiveness and increase our value to customers,” Bailly continued. “For example, to better serve our southwestern customers and counter new molded fiber competitors in the region, we will expand our El Paso operations and add two new molded fiber lines in 2014. This new state-of-the-art equipment, similar to that installed in our Iowa facility in 2013, should improve efficiency and reduce freight costs for product we currently ship from Iowa.”

 

“We also plan to consolidate our Glendale Heights, Illinois, facility into our Grand Rapids, Michigan, facility when the lease ends in July. This decision was driven by a steep rent increase and declining sales at our Illinois facility, and the large savings projected by combining the two facilities. We own our 250,000-square-foot Grand Rapids facility, and it has the space and personnel to absorb our Illinois business. This move also furthers our larger goal of improving efficiency by maintaining fewer, larger plants. The Illinois team has performed admirably; we will work hard to retain as many of those associates as possible, and provide severance benefits for those who do not relocate.”

 

UFP Technologies is a producer of innovative custom-engineered components, products, and specialty packaging.  Using foams, plastics, composites, and natural fiber materials, the Company designs and manufactures a vast range of solutions primarily for the medical, automotive, aerospace and defense, and packaging markets. The UFP team acts as an extension of our customers’ in-house research, engineering, and manufacturing groups, working closely with them to solve their most complex product and packaging challenges.

 

This news release contains statements relating to expected financial performance and/or future business prospects, events and plans that are forward-looking statements.  Such statements include, without limitation, statements about the Company’s prospects, anticipated trends in the different markets in which the Company competes, including the molded fiber, medical, military and automotive markets, expectations regarding customer demand for the Company’s molded fiber product lines, anticipated advantages relating to the Company’s decision to consolidate its Glendale Heights, Illinois facility into its Grand Rapids, Michigan facility and the expected costs savings and efficiencies associated therewith, expectations regarding the Company’s employees affected by the plant consolidation, anticipated advantages of maintaining fewer, larger plants, anticipated advantages the Company expects to realize from its investments and capital expenditures, including the development of and investments in its molded fiber product lines, expectations regarding the manufacturing capacity and efficiencies of the Company’s new production equipment, statements about the Company’s acquisition opportunities and strategies, its participation and growth in multiple markets, its business opportunities, the Company’s growth potential and strategies for growth, anticipated revenues and the timing of such revenues, and any indication that the Company may be able to sustain or increase its sales and earnings or sales and earnings growth rates.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation risks associated with the implementation of new production equipment in a timely, cost-efficient manner, risks that any benefits from such new equipment may be delayed or not fully realized, or that the Company may be unable to fully utilize its expected production capacity, and risks and uncertainties associated with plant closures and expected efficiencies from consolidating manufacturing, the identification of suitable acquisition

 



 

candidates and the successful, efficient execution of acquisition transactions and integration of any such acquisition candidates, as well as other risks and uncertainties that are detailed in the documents filed by the Company with the Securities and Exchange Commission (“SEC”).  Accordingly, actual results may differ materially.  Readers are referred to the documents filed by the Company with the SEC, specifically the last reports on Forms 10-K and 10-Q.  The forward-looking statements contained herein speak only of the Company’s expectations as of the date of this press release.  The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in the Company’s expectations or any change in events, conditions, or circumstances on which any such statement is based.

 



 

Consolidated Condensed Statement of Income

(in thousands, except Per Share Data)

 

 

 

Unaudited

 

 

 

 

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

December 31,

 

December 31,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

34,993

 

$

33,370

 

$

139,223

 

$

130,962

 

Cost of sales

 

24,128

 

23,303

 

98,574

 

92,777

 

Gross profit

 

10,865

 

10,067

 

40,649

 

38,185

 

SG&A

 

5,540

 

5,465

 

23,240

 

21,531

 

Gain on sale of assets

 

 

 

11

 

(12

)

Operating income

 

5,325

 

4,602

 

17,398

 

16,666

 

Interest expense, other income & expenses

 

(76

)

(47

)

(205

)

(92

)

Income before income taxes

 

5,249

 

4,555

 

17,193

 

16,574

 

Income taxes

 

1,872

 

1,352

 

5,917

 

5,679

 

Net income from consolidated operations

 

$

3,377

 

$

3,203

 

$

11,276

 

$

10,895

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

6,888

 

6,724

 

6,824

 

6,679

 

Weighted average diluted shares outstanding

 

7,133

 

7,055

 

7,105

 

7,028

 

Per Share Data

 

 

 

 

 

 

 

 

 

Net income per share outstanding

 

$

0.49

 

$

0.48

 

$

1.65

 

$

1.63

 

Net income per diluted share outstanding

 

$

0.47

 

$

0.45

 

$

1.59

 

$

1.55

 

 

Consolidated Condensed Balance Sheets

(in thousands)

 

 

 

December 31,

 

 

 

2013

 

2012

 

Assets:

 

 

 

 

 

Cash

 

$

37,303

 

$

33,480

 

Receivables

 

17,032

 

17,836

 

Inventories

 

11,048

 

9,695

 

Other current assets

 

3,449

 

3,483

 

Net property, plant, and equipment

 

25,507

 

23,318

 

Other assets

 

10,681

 

10,805

 

Total assets

 

$

105,020

 

$

98,617

 

Liabilities and equity:

 

 

 

 

 

Short-term debt

 

$

976

 

$

1,550

 

Accounts payable

 

3,081

 

4,088

 

Other current liabilities

 

8,265

 

7,593

 

Long-term debt

 

2,867

 

8,314

 

Other liabilities

 

4,241

 

3,811

 

Total liabilities

 

19,430

 

25,356

 

Total equity

 

85,590

 

73,261

 

Total liabilities and stockholders’ equity

 

$

105,020

 

$

98,617